The prognostic value of the temporal course of S100β protein in post-acute severe brain injury: A prospective and observational study

Brain Injury

Volumn 24, Issue 4, 2010, Pages 609-619

  Murillo Cabezas, Francisco ^a   Muñoz Sánchez, Maria Ángeles ^a   Rincón Ferrari, Maria Dolores ^a   Martín Rodríguez, Juan Francisco ^b   Amaya Villar, Rosario ^a   García Gómez, Susana ^a   León Carrión, José ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Acute brain injury; Brain injury biomarker; Brain injury outcome; Serum S100 ; Traumatic brain injury

Indexed keywords

BRAIN PROTEIN; S100 BETA PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BEHAVIOR; BRAIN INJURY; DISEASE COURSE; DISEASE SEVERITY; EVALUATION AND FOLLOW UP; FATALITY; FEMALE; GLASGOW OUTCOME SCALE; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POST ACUTE SEVERE BRAIN INJURY; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PUPIL REFLEX; SURGICAL TECHNIQUE; SURVIVOR;

EID: 77949629040     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699051003652823     Document Type: Article

References (31)

1. León-Carrión J, Domínguez-Morales Mdel R, Barroso y Martín JM, Murillo-Cabezas F. Epidemiology of traumatic brain injury and subarachnoid hemorrhage. Pituitary 2005;8: 197-202.
2. Pelinka LE, Kroepfl A, Schmidhammer R, Krenn M, Buchinger W, Redl H, Raabe A. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. The Journal of Trauma 2004;57:1006-1012.
3. Kochanek PM, Berger RP, Bayir H, Wagner AK, Jenkins LW, Clark RS. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: Diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Current Opinion in Critical Care 2008;14:135-141.
4. Petzold A, Green AJ, Keir G, Fairley S, Kitchen N, Smith M, Thompson EJ. Role of serum S100βas an early predictor of high intracranial pressure and mortality in brain injury: A pilot study. Critical Care Medicine 2002;30:2705-2710.
5. Korfias S, Stranjalis G, Papadimitriou A, Psachoulia C, Daskalakis G, Antsaklis A, Sakas DE. Serum S100βprotein as a biochemical marker of brain injury: A review of current concepts. Current Medicinal Chemistry 2006;13:3719-3731.
6. Bloomfield SM, McKinney J, Smith L, Brisman J. Reliability of S100βin predicting severity of central nervous system injury. Neurocritical Care 2007;6:121-138.
7. Kleindienst A, Bullock RM. A critical analysis of the role of the neurotrophic protein S100βin acute brain injury. The Journal of Neurotrauma 2006;8:1185-1200.
8. Nylén K, Ost M, Csajbok LZ, Nilsson I, Hall C, Blennow K, Nellgård B, Rosengren L. Serum levels of S100β, S100A1B and S100βB are all related to outcome after severe traumatic brain injury. Acta Neurochirurgica 2008;150:221-227.
9. Herrmann M, Curio N, Jost S, Grubich C, Ebert AD, Fork ML, Synowitz H. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. Journal of Neurology, Neurosurgery, and Psychiatry 2001;70:95-100.
10. Woertgen C, Rothoer l RD, Brawanski A. Early S100βserum level correlates to quality of life in patients after severe head injury. Brain Injury 2002;16:807-816.
11. Berger RP. The use of serum biomarkers to predict outcome after traumatic brain injury in adults and children. Journal of Head Trauma Rehabilitation 2006;21:315-333.
12. Raabe A, Grolms C, Sorge O, Zimmermann M, Seifert V. Serum S-100B protein in severe head injury. Neurosurgery 1999;45:477-483.
13. Korfias S, Stranjalis G, Boviatsis E, Psachoulia C, Jullien G, Gregson B, Mendelow AD, Sakas DE. Serum S100βprotein monitoring in patients with severe traumatic brain injury. Intensive Care Medicine 2007;33:255-260.
14. Civil L, Schawab W. The abbreviated injury scale, revision 1985. A condensed chart for clinical use. The Journal of Trauma 1988;28:87-90.
15. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbals WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655.
16. Baker SP, O'Neill B, Haddon Jr W, Long WB. The Injury Severity Score: A method for describing patients with multiple injuries and evaluating emergency care. The Journal of Trauma 1974;14:187-196.
17. Marshall LF, Bowers Marshall S, Klauber MR, van Berkum Clark M, Eisenberg HM, Jane JA, Luerssen TG, Marmarou A, Foulkes MA. A new classification of head injury based on computerized tomography. Journal of Neurosurgery 1991;75 (Suppl):S14-S20.
18. Leal-Noval SR, Muñoz-Gómez M, Arellano-Orden V, Marín-Caballos A, Amaya-Villar R, Marín A, Puppo-Moreno A, Ferrándiz-Millón C, Flores-Cordero JM, Murillo-Cabezas F. Impact of age of transfused blood on cerebral oxygenation in male patients with severe traumatic brain injury. Critical Care Medicine 2008;36:1290-1296.
19. Marín-Caballos AJ, Murillo-Cabezas F, Cayuela- Domínguez A, Domínguez-Roldán JM, Rincón- Ferrari MD, Valencia-Anguita J, Flores-Cordero JM, Muñoz-Sánchez MA. Cerebral perfusion pressure and risk of brain hypoxia in severe head injury: A prospective observational study. Critical Care 2005;9:R670-R676.
20. Jennet B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480-484.
21. Alber B, Hein R, Garbe C, Caroli U, Luppa PB. Multicenter evaluation of the analytical and clinical performance of the Elecsys S100 immunoassay in patients with malignant melanoma. Clinical Chemistry and Laboratory Medicine 2005;43:557-563.
22. Biberthaler P, Linsenmeier U, Pfeifer KJ, Kroetz M, Mussack T, Kanz KG, Hoecherl EF, Jonas F, Marzi I, Leucht P, et al. Serum S100βconcentration provides additional information for the indication of computed tomography in patients after minor head injury: A prospective multicenter study. Shock 2006;25:446-453.
23. Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrika 1991;78:691-692.
24. Hanley JA, McNeil BJ. A method of comparing the areas under the receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-843.
25. Bishop YMM, Fienberg SE, Holland PW. Discrete multivariate analysis: Theory and practise. Cambridge, MA: MIT Press; 1975.
26. Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, van Geel W, de Reus H, Biert J, Verbeek MM. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004;62:1303-1310.
27. Dimopoulou I, Korfias S, Dafni U, Anthi A, Psachoulia C, Jullien G, Sakas DE, Roussos C. Protein S-100b serum levels in trauma-induced brain death. Neurology 2003;60: 947-951.
28. McKeating EG, Andrews PJ, Mascia L. Relationship of neuron specific enolase and protein S-100 concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury. Acta Neurochirurgica Supplement 1998;71:117-119.
29. Ingebrigtsen T, Romner B, Marup-Jensen S, Dons M, Lundqvist C, Bellner J, Alling C, Børgesen SE. The clinical value of serum S-100 protein measurements in minor head injury: A Scandinavian multicentre study. Brain Injury 2000;14:1047-1055.
30. Maas AIR, Stocchetti N, Bulock R. Moderate and severe traumatic brain injury in adults. Lancet Neurology 2008;7: 728-741.
31. Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H. GFAP versus S100βin serum after traumatic brain injury: Relationship to brain damage and outcome. Journal of Neurotrauma 2004;21:1553-1561.